Literature DB >> 2328765

Chloroethylclonidine unmasks a non-alpha-adrenoceptor noradrenaline binding site in the rat aorta.

M A Oriowo1, J A Bevan.   

Abstract

The effect of chloroethylclonidine on noradrenaline-induced contractions of the rat aorta was studied. Chloroethylclonidine (1-5 X 10(-5) M) shifted noradrenaline dose-response curve to the right approximately 5000-fold without depressing the maximum. The response to noradrenaline after chloroethylclonidine was not antagonized by phenoxybenzamine (10(-7) M), prazosin (10(-7) M), WB 4101 (10(-7) M) nor yohimbine (10(-5) M) and is therefore not mediated via alpha 1-adrenoceptors. These results would suggest that there is a homogenous population of chloroethylclonidine-sensitive alpha 1-adrenoceptors in the rat aorta and that chloroethylclonidine treatment reveals a non-alpha-adrenoceptor noradrenaline binding site in this tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328765     DOI: 10.1016/0014-2999(90)90482-l

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  The role of alpha 1-adrenoceptor subtypes in the phasic and tonic responses to phenylephrine in the longitudinal smooth muscle of the rat portal vein.

Authors:  H R Schwietert; M A Gouw; D Wilhelm; B Wilffert; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

2.  Investigation of the actions of chloroethylclonidine in rat aorta.

Authors:  M O'Rourke; S Kearns; J R Docherty
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

3.  Mediation of noradrenaline-induced contractions of rat aorta by the alpha 1B-adrenoceptor subtype.

Authors:  R Testa; L Guarneri; E Poggesi; I Simonazzi; C Taddei; A Leonardi
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

4.  Chloroethylclonidine irreversibly activates postjunctional alpha 2-adrenoceptors in the dog saphenous vein.

Authors:  J P Nunes; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.